1. Home
  2. PD vs AMPH Comparison

PD vs AMPH Comparison

Compare PD & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$13.03

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.87

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
AMPH
Founded
2009
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
PD
AMPH
Price
$13.03
$26.87
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$17.70
$31.00
AVG Volume (30 Days)
2.9M
389.3K
Earning Date
11-25-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.63
2.27
Revenue
$489,207,000.00
$723,305,000.00
Revenue This Year
$8.16
$1.35
Revenue Next Year
$3.88
$5.10
P/E Ratio
$8.00
$11.81
Revenue Growth
7.01
N/A
52 Week Low
$11.13
$20.39
52 Week High
$20.00
$39.56

Technical Indicators

Market Signals
Indicator
PD
AMPH
Relative Strength Index (RSI) 45.45 53.61
Support Level $12.69 $26.26
Resistance Level $13.11 $27.44
Average True Range (ATR) 0.36 0.83
MACD 0.14 0.04
Stochastic Oscillator 80.60 71.43

Price Performance

Historical Comparison
PD
AMPH

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: